Australia's most trusted
source of pharma news
Wednesday, 12 November 2025
Posted 11 November 2025 AM
A chaotic week of one-upmanship and legal challenges saw Pfizer win the bidding war for obesity biotech Metsera, with an increased offer getting a push over the line with the help of a phone call from regulators.
When Novo swooped in with a surprise bid for Metsera, Pfizer launched legal action to prevent the biotech backing out of the deal the two had signed in September, but its request for a temporary restraining order was rejected by the Delaware Chancery Court.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.